Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,367 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $373.09 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $299.82 | 6 | $0 (2019) |
| PFIZER INC. | $237.30 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $174.85 | 6 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $169.00 | 9 | $0 (2019) |
| Abbott Laboratories | $50.94 | 3 | $0 (2017) |
| Melinta Therapeutics, LLC | $28.12 | 1 | $0 (2020) |
| Nabriva Therapeutics, plc | $22.76 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $10.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $123.77 | 1 | BOSTON SCIENTIFIC CORPORATION ($123.77) |
| 2020 | $324.92 | 5 | Boston Scientific Corporation ($249.32) |
| 2019 | $364.21 | 8 | Merck Sharp & Dohme Corporation ($280.87) |
| 2018 | $127.08 | 7 | Janssen Pharmaceuticals, Inc ($59.46) |
| 2017 | $426.61 | 17 | PFIZER INC. ($170.60) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/20/2021 | BOSTON SCIENTIFIC CORPORATION | RESONATE (Device) | Food and Beverage | Cash or cash equivalent | $123.77 | General |
| Category: RESONATE | ||||||
| 11/19/2020 | Boston Scientific Corporation | LUX-DX (Device) | Food and Beverage | In-kind items and services | $127.39 | General |
| Category: THERAPIES | ||||||
| 09/10/2020 | Boston Scientific Corporation | SQ-RX PULSE GENERATOR (Device) | Food and Beverage | In-kind items and services | $121.93 | General |
| Category: TACHY | ||||||
| 03/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Antibiotic | ||||||
| 01/21/2020 | Melinta Therapeutics, LLC | Orbactiv (Drug), Vabomere, Baxdela | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: ANTIBIOTICS | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/26/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $33.15 | General |
| 11/21/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $119.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/20/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.62 | General |
| Category: Cardiovascular | ||||||
| 02/21/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/13/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/26/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.84 | General |
| Category: Cardiovascular | ||||||
| 04/12/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Cardiovascular | ||||||
| 02/21/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/17/2017 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2017 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/12/2017 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 708 | 1,331 | $193,208 | $76,541 |
| 2022 | 10 | 587 | 1,176 | $208,753 | $79,701 |
| 2021 | 8 | 521 | 890 | $124,146 | $68,086 |
| 2020 | 9 | 509 | 855 | $119,528 | $67,612 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 250 | 742 | $70,297 | $30,079 | 42.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 256 | 277 | $65,379 | $25,863 | 39.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 193 | $29,988 | $12,024 | 40.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 79 | 81 | $16,650 | $5,067 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 38 | $10,894 | $3,508 | 32.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 205 | 751 | $113,865 | $44,492 | 39.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 140 | 146 | $32,906 | $12,570 | 38.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 75 | 75 | $21,459 | $7,651 | 35.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 52 | $11,270 | $4,340 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 17 | $7,191 | $2,703 | 37.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 41 | 42 | $6,427 | $2,294 | 35.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $6,414 | $2,069 | 32.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 17 | 17 | $3,631 | $1,430 | 39.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 21 | 35 | $2,870 | $1,137 | 39.6% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 16 | 18 | $2,720 | $1,014 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 183 | 503 | $55,833 | $31,019 | 55.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 145 | 151 | $25,368 | $13,843 | 54.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 39 | 73 | $11,680 | $6,406 | 54.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 52 | 53 | $11,236 | $5,922 | 52.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 30 | $9,360 | $5,214 | 55.7% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 27 | 27 | $5,616 | $2,973 | 52.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 34 | 35 | $3,955 | $2,143 | 54.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 18 | $1,098 | $565.76 | 51.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 102 | 245 | $39,200 | $22,316 | 56.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 135 | 309 | $34,299 | $19,596 | 57.1% |
About Imran Khan
Imran Khan is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992908123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Imran Khan has received a total of $1,367 in payments from pharmaceutical and medical device companies, with $123.77 received in 2021. These payments were reported across 38 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,367).
As a Medicare-enrolled provider, Khan has provided services to 2,325 Medicare beneficiaries, totaling 4,252 services with total Medicare billing of $291,940. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Pasadena, CA
- Active Since 06/06/2007
- Last Updated 09/09/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992908123
Products in Payments
- ELIQUIS (Drug) $339.33
- ZERBAXA (Drug) $228.40
- XARELTO (Drug) $174.85
- LUX-DX (Device) $127.39
- RESONATE (Device) $123.77
- SQ-RX PULSE GENERATOR (Device) $121.93
- OPDIVO (Biological) $66.97
- CardioMEMS HF System (Device) $50.94
- DIFICID (Drug) $38.27
- Orbactiv (Drug) $28.12
- Xenleta (Drug) $22.76
- ENTRESTO (Drug) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882